APA (7th ed.) Citation

Ferreira-Hermosillo, A., Molina-Ayala, M. A., Molina-Guerrero, D., Garrido-Mendoza, A. P., Ramírez-Rentería, C., Mendoza-Zubieta, V., . . . Mercado, M. (2020). Efficacy of the treatment with dapagliflozin and metformin compared to metformin monotherapy for weight loss in patients with class III obesity: A randomized controlled trial. Trials, 21(1), 1. https://doi.org/10.1186/s13063-020-4121-x

Chicago Style (17th ed.) Citation

Ferreira-Hermosillo, Aldo, Mario Antonio Molina-Ayala, Diana Molina-Guerrero, Ana Pamela Garrido-Mendoza, Claudia Ramírez-Rentería, Victoria Mendoza-Zubieta, Etual Espinosa, and Moisés Mercado. "Efficacy of the Treatment with Dapagliflozin and Metformin Compared to Metformin Monotherapy for Weight Loss in Patients with Class III Obesity: A Randomized Controlled Trial." Trials 21, no. 1 (2020): 1. https://doi.org/10.1186/s13063-020-4121-x.

MLA (9th ed.) Citation

Ferreira-Hermosillo, Aldo, et al. "Efficacy of the Treatment with Dapagliflozin and Metformin Compared to Metformin Monotherapy for Weight Loss in Patients with Class III Obesity: A Randomized Controlled Trial." Trials, vol. 21, no. 1, 2020, p. 1, https://doi.org/10.1186/s13063-020-4121-x.